Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Acifran Workflows for GPCR Lipid Signaling
2026-09-03
Acifran enables matched HCAR2/GPR109A and HCAR3/GPR109B experiments that connect receptor activation with cAMP and lipid-pathway readouts. This practical guide translates recent cryo-EM findings into assay design, dose planning, structural validation, and troubleshooting strategies.
-
S-Nitrosylation Coordinates Al Resistance in Arabidopsis
2026-09-03
A 2026 Molecular Plant study identifies nitric oxide–dependent S-nitrosylation as a dual regulatory mechanism linking external and internal aluminum detoxification in Arabidopsis. The work shows that modification of STOP1 and STAR1 has opposing effects on protein stability, providing a mechanistic framework for interpreting redox regulation of aluminum resistance and designing thiol-centered validation assays.
-
Hoechst 33342/PI Double Staining Kit for RCC
2026-09-02
Separate chromatin condensation from membrane rupture in one rapid fluorescence workflow for renal cell carcinoma research. The assay is especially useful for comparing syringin, sunitinib, and combination treatments while distinguishing apoptotic morphology from late membrane failure.
-
Cycloastragenol Protects Against GIONFH Bone Loss
2026-09-02
This in vivo study identifies osteoclast overactivity as a modifiable component of glucocorticoid-induced osteonecrosis of the femoral head and shows that cycloastragenol preserves femoral-head structure in methylprednisolone-treated rats. By combining micro-CT, angiography, histology, gene expression, and protein analysis, the work connects reduced bone resorption with smaller necrotic lesions and improved local blood supply.
-
SUCLG1-Driven Histone Succinylation in AML
2026-09-01
A 2025 Cell Reports study identifies SUCLG1 as a metabolic regulator of histone succinylation in acute myeloid leukemia. Its findings connect mitochondrial succinyl-CoA handling to BRD4-dependent oncogene transcription, leukemia-cell proliferation, and disease progression in xenograft models.
-
SCH772984 HCl: ERK1/2 Workflow Guide
2026-09-01
SCH772984 HCl is a nanomolar ERK1/2 inhibitor for resolving MAPK pathway output, drug resistance, and ERK-linked TERT regulation. This practical guide connects acute phospho-signaling assays with chromatin, transcriptional, and antiproliferative readouts while highlighting controls that prevent misleading conclusions.
-
Targeting uPAR–uPA to Block Cancer Cell Invasion
2026-08-31
The reference study used explicit-solvent molecular dynamics and ensemble virtual screening to identify small molecules that disrupt the tight uPAR–uPA protein–protein interaction, including the derivative IPR-803. Biochemical and cellular experiments connected receptor-level inhibition with reduced breast cancer cell invasion while showing that migration and adhesion were comparatively unaffected, providing a mechanistic basis for selective anti-invasive assay design.
-
Novel PDK4 Inhibitors for Metabolic Disease
2026-08-31
The 2019 Journal of Medicinal Chemistry study identified compound 8c as an allosteric PDK4 inhibitor with biochemical activity, metabolic stability, and efficacy signals in obesity and allergy models. Its integrated medicinal chemistry, pharmacokinetic, docking, and in vivo strategy illustrates how PDK4 modulation can be evaluated across metabolic, inflammatory, and cancer-related contexts while highlighting the need for careful mechanistic validation.
-
MK-8745: Aurora A Inhibitor Assay Workflows
2026-08-30
MK-8745 converts Aurora A biology into practical assays for mitotic arrest, tetraploidy, and apoptosis. This workflow connects high-risk retinoblastoma findings with carefully controlled cell-based, lymphoma, and xenograft experiments.
-
ZDHHC4 Palmitoylation and TRPV1 Pain Relief
2026-08-29
A 2025 EMBO Reports study identifies ZDHHC4-mediated S-palmitoylation as a mechanism that reduces TRPV1 activity during inflammatory pain relief by promoting lysosomal degradation of the channel. The work also positions APT1-dependent depalmitoylation as a counter-regulatory process that can restore nociceptive signaling.
-
Berbamine Hydrochloride and Ferroptosis Strategy
2026-08-28
Berbamine hydrochloride offers a mechanistically rich research entry point for connecting STAT3, calcium homeostasis, NF-κB activity, and ferroptosis-resistance biology. This translational framework uses the METTL16-SENP3-LTF axis in hepatocellular carcinoma to define testable hypotheses while separating established product data from future experimental validation.
-
D-N-Acetylgalactosamine: Protocol and QC Guide
2026-08-28
D-N-Acetylgalactosamine (SKU B7904) provides a defined, water-compatible amino sugar for workflows examining glycoprotein composition, brain heteropolysaccharides, and related glycosylation pathways. It is appropriate for aqueous or validated DMSO-based procedures, but should not be selected for ethanol-based systems or long-term storage of prepared solutions.
-
FerroOrange and the Translational Iron Signal
2026-08-27
A mechanistic and strategic guide to using FerroOrange, a live-cell Fe²⁺ fluorescent probe, to connect intracellular iron detection with ferroptosis, macrophage biology, and translational research.
-
2X Taq PCR Master Mix (with dye): Assay QC
2026-08-27
A scenario-driven guide to using 2X Taq PCR Master Mix (with dye), SKU K1034, as an orthogonal molecular quality-control tool alongside cell viability, proliferation, and cytotoxicity assays. It explains assay compatibility, endpoint-PCR interpretation, protocol setup, TA cloning, and practical vendor-selection criteria.
-
miR-18a, ALOXE3, and Glioblastoma Ferroptosis
2026-08-26
The reference study identifies a miR-18a–ALOXE3 axis that links lipid metabolism, ferroptosis resistance, and migration in glioblastoma. Its findings position ALOXE3-mediated lipid signaling as a mechanistic framework for studying tumor growth and provide a basis for evaluating p53-linked interventions without equating them to validated GBM therapies.